Top Markets
#1 Cortex Cortex +174.22%
#2 GEKKO GEKKO +44.25%
#3 ADO Protocol ADO Protocol +18.41%
#4 o1.exchange o1.exchange +10.98%
#5 Official Trump Official Trump +10.62%
#6 aelf aelf +10.25%
#7 DAPPOS DAPPOS +9.52%
#8 Bless Bless +8.43%
#9 Status Status +7.95%
#10 Seeker Seeker +7.66%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rank in Stocks #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Share Price
$59.98
Last synced: 2024-12-13
Market Cap
$1.22B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Longboard Pharmaceuticals, Inc. (LBPH)

Category

Healthcare
Number of shares outstanding for Longboard Pharmaceuticals, Inc. (LBPH)
Number of shares outstanding as of September 2024: 38.96M
According to Longboard Pharmaceuticals, Inc. latest financial reports and stock price the company's current number of shares outstanding is 38.96M. At the end of December 2022 the company had 17.15M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Longboard Pharmaceuticals, Inc. (LBPH) from 2020 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 38.96M 71.42%
2023 22.73M 32.51%
2022 17.15M 0.47%
2021 17.07M -3.38%
2020 17.67M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 551.74%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 59.62%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 1,129.32%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 916.49%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH